OBJECTIVE: Many bloodstream infections (BSIs) occurring in patients with febrile neutropenia following cytotoxic chemotherapy are due to translocation of intestinal microbiota. However, these infections meet the National Healthcare Safety Network (NHSN) definition of central line-associated BSIs (CLABSIs). We sought to determine the differences in the microbiology of NHSN-defined CLABSIs in patients with and without neutropenia and, using these data, to propose a modification of the CLABSI definition. DESIGN: Retrospective review. SETTING: Two large university hospitals over 18 months. METHODS: All hospital-acquired BSIs occurring in patients with central venous catheters in place were classified using the NHSN CLABSI definition. Patients with postchemotherapy neutropenia (500 neutrophils/mm(3) or lower) at the time of blood culture were considered neutropenic. Pathogens overrepresented in the neutropenic group were identified to inform development of a modified CLABSI definition. RESULTS: Organisms that were more commonly observed in the neutropenic group compared with the nonneutropenic group included Escherichia coli (22.7% vs 2.5%; P < .001) but not other Enterobacteriaceae, Enterococcus faecium (18.2% vs 6.1%; P = .002), and streptococci (18.2% vs 0%; P < .001). Application of a modified CLABSI definition (removing BSI with enterococci, streptococci, or E. coli) excluded 33 of 66 neutropenic CLABSIs and decreased the CLABSI rate in one study hospital with large transplant and oncology populations from 2.12 to 1.79 cases per 1,000 line-days. CONCLUSIONS: Common gastrointestinal organisms were more common in the neutropenia group, suggesting that many BSIs meeting the NHSN criteria for CLABSI in the setting of neutropenia may represent translocation of gut organisms. These findings support modification of the NHSN CLABSI definition.
OBJECTIVE: Many bloodstream infections (BSIs) occurring in patients with febrile neutropenia following cytotoxic chemotherapy are due to translocation of intestinal microbiota. However, these infections meet the National Healthcare Safety Network (NHSN) definition of central line-associated BSIs (CLABSIs). We sought to determine the differences in the microbiology of NHSN-defined CLABSIs in patients with and without neutropenia and, using these data, to propose a modification of the CLABSI definition. DESIGN: Retrospective review. SETTING: Two large university hospitals over 18 months. METHODS: All hospital-acquired BSIs occurring in patients with central venous catheters in place were classified using the NHSN CLABSI definition. Patients with postchemotherapy neutropenia (500 neutrophils/mm(3) or lower) at the time of blood culture were considered neutropenic. Pathogens overrepresented in the neutropenic group were identified to inform development of a modified CLABSI definition. RESULTS: Organisms that were more commonly observed in the neutropenic group compared with the nonneutropenic group included Escherichia coli (22.7% vs 2.5%; P < .001) but not other Enterobacteriaceae, Enterococcus faecium (18.2% vs 6.1%; P = .002), and streptococci (18.2% vs 0%; P < .001). Application of a modified CLABSI definition (removing BSI with enterococci, streptococci, or E. coli) excluded 33 of 66 neutropenic CLABSIs and decreased the CLABSI rate in one study hospital with large transplant and oncology populations from 2.12 to 1.79 cases per 1,000 line-days. CONCLUSIONS: Common gastrointestinal organisms were more common in the neutropenia group, suggesting that many BSIs meeting the NHSN criteria for CLABSI in the setting of neutropenia may represent translocation of gut organisms. These findings support modification of the NHSN CLABSI definition.
Authors: Susan E Coffin; Sarah B Klieger; Christopher Duggan; W Charles Huskins; Aaron M Milstone; Gail Potter-Bynoe; Bram Raphael; Thomas J Sandora; Xiaoyan Song; Danielle M Zerr; Grace M Lee Journal: Infect Control Hosp Epidemiol Date: 2014-10-02 Impact factor: 3.254
Authors: Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann Journal: GMS Hyg Infect Control Date: 2016-05-12
Authors: Fiona B Tamburini; Tessa M Andermann; Ekaterina Tkachenko; Fiona Senchyna; Niaz Banaei; Ami S Bhatt Journal: Nat Med Date: 2018-10-15 Impact factor: 53.440
Authors: Hye Kyung Seo; Joo-Hee Hwang; Myoung Jin Shin; Su Young Kim; Kyoung-Ho Song; Eu Suk Kim; Hong Bin Kim Journal: J Korean Med Sci Date: 2018-10-04 Impact factor: 2.153
Authors: Olaf Penack; Carolin Becker; Dieter Buchheidt; Maximilian Christopeit; Michael Kiehl; Marie von Lilienfeld-Toal; Marcus Hentrich; Marc Reinwald; Hans Salwender; Enrico Schalk; Martin Schmidt-Hieber; Thomas Weber; Helmut Ostermann Journal: Ann Hematol Date: 2014-04-29 Impact factor: 3.673
Authors: C Gudiol; S Nicolae; C Royo-Cebrecos; M Aguilar-Guisado; I Montero; C Martín-Gandul; M Perayre; D Berbel; M Encuentra; M Arnan; J M Cisneros-Herreros; J Carratalà Journal: Trials Date: 2018-05-02 Impact factor: 2.279
Authors: Scott K Dessain; Çagla Tükel; Sarah A Tursi; Rama Devudu Puligedda; Paul Szabo; Lauren K Nicastro; Amanda L Miller; Connie Qiu; Stefania Gallucci; Norman R Relkin; Bettina A Buttaro Journal: Nat Commun Date: 2020-02-21 Impact factor: 14.919